Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks | Zendy

T. Anekthana | Zendy; S. Pukrittayakamee | Zendy; W. Ratanasuwan | Zendy; P. Jittamala | Zendy; P. Werarak | Zendy; P. Charunwatthana | Zendy; S. Suwanagool | Zendy; Saranath Lawpoolsri | Zendy; K. Stepniewska | Zendy; P. Sapchookul | Zendy; P. Puthavathana | Zendy; Claudio Tadashi Fukuda | Zendy; N. Lindegardh | Zendy; Joel Tärning | Zendy; Nicholas J. White | Zendy; N. Day | Zendy; Walter Taylor | Zendy

Open Access

Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks

Author(s) -

T. Anekthana,

S. Pukrittayakamee,

W. Ratanasuwan,

P. Jittamala,

P. Werarak,

P. Charunwatthana,

S. Suwanagool,

Saranath Lawpoolsri,

K. Stepniewska,

P. Sapchookul,

P. Puthavathana,

Claudio Tadashi Fukuda,

N. Lindegardh,

Joel Tärning,

Nicholas J. White,

N. Day,

Walter Taylor

Publication year - 2013

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkt194

Subject(s) - zanamivir , oseltamivir , medicine , neuraminidase inhibitor , randomized controlled trial , placebo , chemoprophylaxis , healthcare worker , double blind , emergency medicine , anesthesia , health care , covid-19 , alternative medicine , disease , pathology , infectious disease (medical specialty) , economics , economic growth

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research